IL6 and ovarian cancer: Here, we report for the first time that the pro-migratory effect of IL-6 on ovarian cancer cells is suppressed if glucose is not available for triggering the glycolytic pathway, indicating that this pro-inflammatory cytokine activates its oncogenic downstream pathways only when glucose is metabolized.